Novozymes A/S
NSIS-B
Κατάταξη σε μετοχές
#803
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global... Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.
Τιμή μετοχής
$73.15
Κεφαλαιοποίηση
$30.18B
Αλλαγή (1 ημέρα)
-0.19%
Αλλαγή (1 έτος)
28.23%
Χώρα
DK
Εμπόριο Novozymes A/S (NSIS-B)
Κατηγορία
Basic Materials
Κεφαλαιοποίηση αγοράς του Novozymes A/S(NSIS-B)
Κεφαλαιοποίηση: $30.18B
Μέχρι το October 2026, η Novozymes A/S έχει χρηματιστηριακή αξία $30.18B. Αυτό καθιστά τη Novozymes A/S την 803rd πιο πολύτιμη εταιρεία στον κόσμο βάσει της κεφαλαιοποίησης σύμφωνα με τα δεδομένα μας. Η χρηματιστηριακή κεφαλαιοποίηση είναι η συνολική αγοραία αξία των μετοχών μιας εισηγμένης εταιρείας και χρησιμοποιείται συνήθως για να προσδιοριστεί η αξία μιας εταιρείας.
Ιστορικό κεφαλαιοποίησης αγοράς της Novozymes A/S από 2000 έως 2026
NSIS-B σε σύγκριση με τα 5 πιο δημοφιλή stocks
| Η τιμή για NSIS-B | Το περιουσιακό στοιχείο B | Η κεφαλαιοποίηση αγοράς του B | Αποτελέσματα | |
|---|---|---|---|---|
$19,160.43
$15.64B
|
$5.252T | +33,488.70% | ||
|
$18,244.52
$15.64B
|
$5.001T | +31,883.09% | ||
|
$15,234.50
$15.64B
|
$4.176T | +26,606.44% | ||
|
$14,475.39
$15.64B
|
$3.968T | +25,275.70% | ||
|
$10,349.67
$15.64B
|
$2.837T | +18,043.23% |
